Exosome Technologies Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis
MARKET OVERVIEW
Exosomes are small vesicles released by cells containing diverse biomolecules, including proteins, nucleic acids, and lipids. These extracellular vesicles are pivotal for cell-to-cell communication and are present in bodily fluids like blood, urine, and cerebrospinal fluid. Exosomes can be used as biomarkers for disorder diagnosis and monitoring and also can be used as targeted drug delivery systems. The application of exosome technologies has significant potential to advance disease diagnosis, treatment, and scientific research.
The “Global Exosome Technologies Market Analysis to 2028” is a specialized and in-depth study of the medical devices industry with a special focus on global market trend analysis. The report aims to provide an overview of the exosome technologies market with detailed market segmentation by exosome type, application, end user, and geography. The report provides key statistics on the market status of the leading exosome technologies market players and offers key trends and opportunities in the market.
MARKET DRIVERS
Factors driving the exosome technologies market growth are increasing awareness and understanding, advancements in isolation and characterization techniques, and rising prevalence of chronic diseases. However, the high cost of exosome-based products and lack of standardization in isolation, and stringent regulatory needs for approval and commercialization of exosome products are the factors restraining exosome technologies market growth. The rising prevalence of chronic diseases is boosting the market growth. For instance, the International Agency for Research on Cancer (IARC) estimations reveal that globally, around 1 in 5 people develop cancer. Recent estimates show that over 50 million people live within five years of a precedent cancer diagnosis. Also, the high prevalence of skin disorders such as hyperpigmentation or hyper melanosis among people globally as exosomes derived from mesenchymal stem/stromal cell (MSC) cultures shows potential as a next-generation cell-free therapeutic option. In addition, exosome technology market demand will be driven by the increasing need for optimization and innovation of exosome loading capacities and methods to improve target drug efficacy in the coming years. Moreover, changing environmental conditions and human behavior affect the spread and impact of infectious diseases. Thus, the rising prevalence of chronic diseases is fueling the exosome technologies market growth.
GLOBAL SEGMENTAL ANALYSIS
The global exosome technologies market is segmented into exosome type, application, end user. Based on exosome type the market is segmented into loaded cargo and non-cargo. Loaded cargo segment is further sub segmented as peptide, siRNA, mRNA, miRNA, protein, chemical, and others. Further, non-cargo is segmented as HEK293 cells, MSCs, platelets, erythrocytes, natural killer cells, and others. Based on application, the market is segmented into therapeutics and diagnostics. Further, therapeutics segment is further sub segmented as oncology, neurodegenerative diseases, cardiovascular diseases, infectious diseases, cosmetics, and others. The market is segmented into healthcare providers, pharmaceutical & biotechnology companies, and others based on end-user.
Based on the exosome type, the loaded cargo dominates the global exosome technologies market share. The loaded cargo segment had held the largest exosome technologies market share in 2020. This is because the exosome cargo relating to the origin of cells has become much more specific. It is one of the key factors driving the growth of the exosome technologies market, as exosomes are used to transport cargo such as protein, lipids, and nucleic acids between cells, making them a promising tool for drug delivery and biomarker discovery. Thus, the loaded cargo segment drives the growth of the exosome technologies market.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides an overview and forecast of the global market based on various segments. It also provides exosome technologies market size and forecast estimates from the year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), the Middle East & Africa (MEA), and South & central America. The exosome technologies market by each region is later sub-segmented by respective countries and segments. The report covers the analysis and forecast of 18 countries globally along with the current trend and opportunities prevailing in the region.
The report analyzes factors affecting the market from both the demand and supply side and further evaluates market dynamics affecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trends. The report also provides an exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA, and South & central America after evaluating political, economic, social and technological factors affecting the exosome technologies market in these regions.
North America is anticipated to account for the highest market share in the next few years. The United States is a highly profitable market in the region. Rapidly commercializing exosome products is expected to be driven by increased demand for new cancer treatments and diagnostics. There is a strong expectation of increased market value in North America due to government initiatives designed to promote the production of these products. Global biotech companies in the region are working to scale up the production of therapeutic extracellular vesicles originating from MSC and other stem cells through partnerships with governments and private universities.
Exosome Technologies Market Report Analysis
CAGR (2023 - 2031)
US$ XX Million
US$ XX Million
Report Coverage
Key Players
Regional Overview
Market Segmentation
By Exosome Type
By Application
By End-user
The report covers key developments in the Exosome Technologies Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals, and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved the way for the expansion of business and the customer base of market players. The market payers from the Exosome Technologies Market are anticipated to have lucrative growth opportunities in the future with the rising demand for Exosome Technologies in the global market.
The report also includes the profiles of key companies along with their SWOT analysis and market strategies in the Exosome Technologies Market. In addition, the report focuses on leading industry players with information such as company profiles, components, and services offered, financial information of the last 3 years, the key development in the past five years.
- DANAHER CORP
- PALL CORPORATION
- FUJIFILM HOLDINGS CORP.
- LONZA
- MILTENYI BIOTEC
- BIO-TECHNE CORP.
- QIAGEN
- THERMO FISHER SCIENTIFIC, INC
- ABCAM PLC
- ROOSTERBIO, INC.
Recent Developments
- In November 2021, Lonza, a global manufacturing partner to the pharmaceutical, biotech, and nutrition industries, declared the acquisition of the service unit from Exosomics, a leading extracellular vesicles biotech company. The contract shall include Exosomics' Service Team, Services Assets, and Laboratory in Siena, Italy.
- In September 2020, Bio-Techne Corporation and QIAGEN N.V. announced the expansion and extension of a non-exclusive partnership to co-market exosome technology to existing and potential biopharma partners and the joint development of new exosome-based products.
- In March 2023, RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (hMSCs), highly engineered media, development services, cell engineering, and advanced therapy bioprocess solutions, today announced that it has selected Repligen Corporation, a life sciences company focused on bioprocessing technology leadership, as a collaboration partner to advance scalable exosome bioprocessing. In collaboration with Repligen, Rooster Biotechnologies shall develop solutions for producing exosomes using Scalable and Low shear Technology, allowing the successful commercialization of these advanced therapies.
The Insight Partner’s dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.
Exosome Technologies Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2023 | US$ XX Million |
| Market Size by 2031 | US$ XX Million |
| Global CAGR (2023 - 2031) | XX% |
| Historical Data | 2021-2022 |
| Forecast period | 2024-2031 |
| Segments Covered |
By Exosome Type
|
| Regions and Countries Covered | North America
|
| Market leaders and key company profiles |
|
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
The List of Companies
1. DANAHER CORP
2. PALL CORPORATION
3. FUJIFILM HOLDINGS CORP.
4. LONZA
5. MILTENYI BIOTEC
6. BIO-TECHNE CORP.
7. QIAGEN
8. THERMO FISHER SCIENTIFIC, INC
9. ABCAM PLC
10. ROOSTERBIO, INC.
Get Free Sample For